647 research outputs found

    Molecular Packing in Crystals of Phenoselenazine

    Get PDF
    The crystal structure of phenoselenazine was solved by molecular-packing analysis. Trial models of the rigid molecule were oriented and positioned in the Cheshire cell. The refinement was carried out by structure-factor least-squares calculations using individual anisotropic temperature factors. The final discrepancy index was R = 0.051 for 601 reflexions which were more than two standard deviations above background. The unit cell with a= 7.829 (5), b = 20.909 (4) and c= 5.927 (7)/~ contains four molecules. The space group is P2~2121. The molecule has the same folded configuration as phenothiazine but is more open. The dihedral angle is 149"6 °

    The Role of Diet, Alcohol, BMI, and Physical Activity in Cancer Mortality: Summary Findings of the EPIC Study

    Get PDF
    Evidence on the impact of diet, alcohol, body-mass index (BMI), and physical activity on mortality due to cancer and other cancer-related outcomes is still scarce. Herein, we reviewed the contribution of the European Prospective Investigation into Cancer and Nutrition (EPIC) study to the current state of the art on the role of these factors in cancer mortality. We identified 45 studies using a rapid systematic review methodology. Dietary factors associated with reduced cancer mortality included raw vegetable intake; dietary fiber intake; the Mediterranean diet; other dietary scores; other diet patterns including low meat eaters, vegetarians/vegans, or fish eaters; dietary intake (or biomarkers) of some vitamins (e.g., vitamin D, vitamin K2, or Vitamin C); and intake of lignans. Physical activity and following healthy lifestyle recommendations also reduced cancer mortality risk. In contrast, dietary factors associated with higher cancer mortality risk included poor diet quality, consumption of alcohol and soft drinks including juice, and, to a lesser extent, intake of some fatty acids. Excess weight and obesity also increased the risk of cancer mortality. The EPIC study holds valuable information on diet and lifestyle factors and offers a unique opportunity to identify key diet-related factors for cancer mortality prevention

    Descripción de índices basados en la adhesión al patrón dietético mediterráneo: una revisión

    Get PDF
    Introduction: diet quality indexes are tools are aimed at quantifying the compliance to a defined dietary pattern. These indexes are a combined measure of dietary factors (food groups, foods, nutrients and ratios) and/or lifestyles factors. The Mediterranean Diet (MD) is a dietary pattern characterized by their positive effects against chronic diseases. There have been many indexes proposed for the assessment of this dietary pattern. An evaluation of their composition and health benefits is therefore convenient. Objective: the objective is to evaluate indexes of adherence to the MD with regard to their definition, methodological issues and validation as reported in epidemiological studies. Methods: we searched in PubMed for studies that developed MD Indexes up to October 2014. Results: a total number of 22 indexes were identified, with differences regarding the number of components (7-28), scoring (0, 1, 2, 3, 4, 5, 8 or 10, in case of compliance), range (0-100) and type of components (which could be food groups/foods or their combination, with nutrients). Among the positive components, fruits and vegetables were the most common and meats, among the negative components. There were also differences with regard to their composition and evaluation (e.g. criteria of moderate alcohol consumption), as well as with the scoring system (in medians, terciles or established servings).Conclusions: this review suggests that since there is great heterogeneity in the definition of MD. It would be therefore convenient to establish more clearly the components to be included and to establish commonly defined criteria to quantify this dietary pattern.Introducción: los índices de calidad la de dieta son herramientas que sirven para cuantificar el cumplimiento de un patrón dietético definido. Estos índices son una medida combinada de factores dietéticos (grupos alimenticios, alimentos, nutrientes y ratios) y/o estilos de vida. La dieta mediterránea (DM) es un patrón dietético que se caracteriza por sus efectos positivos contra ciertas enfermedades crónicas. Existen numerosos índices propuestos para la valoración de este patrón dietético. Es por lo tanto conveniente una evaluación de su composición y sus efectos sobre la salud. Objetivo: el objetivo es evaluar los índices de adhesión al patrón dietético mediterráneo en cuanto a su definición, aspectos metodológicos y validación en estudios epidemiológicos. Métodos: se buscaron en PubMed estudios que desarrollaron índices de DM hasta octubre de 2014. Resultados: se identificaron un total de 22 índices, con diferencias en cuanto al número de componentes (7-28), puntuación (0, 1, 2, 3, 4, 5, 8 o 10, en el caso de cumplimiento), rango (0-100) y tipo de componentes (grupos de alimentos/alimentos o su combinación con nutrientes). Entre los componentes positivos, los más comunes fueron frutas y verduras, y carnes entre los negativos. También hubo diferencias con respecto a su composición y evaluación (p. ej. criterios de consumo moderado de alcohol), así como con el sistema de puntuación (en medianas, terciles o raciones establecidas). Conclusiones: esta revisión sugiere que existe una gran heterogeneidad en la definición de DM. Sería por tanto apropiado establecer con mayor claridad los componentes que deben incluirse, así como definir criterios comunes para cuantificar este patrón dietético.This work was supported by the Spanish Ministry of Health. Health Research Fund. PI12/00002, co-funded ERDF and It’s part of the doctoral thesis named: “Relación entre ingesta y acumulación de productos de Maillard de la dieta con el status endógeno antioxidante/oxidativo/ inflamatorio individual (“Indice de balance oxidativo”) y con la calidad de la dieta

    A Review of A Priori Defined Oxidative Balance Scores Relative to Their Components and Impact on Health Outcomes

    Get PDF
    Oxidative Balance Scores (OBSs) are tools that have emerged to evaluate the global balance of individuals’ oxidation—reduction status. The aim was to compare OBSs available in the literature regarding their characteristics and associations with chronic diseases in epidemiological studies. Studies that developed OBSs were searched in PubMed until August 2018. A total of 21 OBSs were identified. These OBSs presented di erent scoring schemes and di erent types of anti- and pro-oxidant components, including dietary factors (dietary intake and/or nutrient biomarkers), lifestyle factors, and medications. Most OBSs were based on over 10 components, and some included only dietary factors. Few considered weighted components in the score. Only three OBSs were validated as potential surrogates of oxidative balance through inflammation and OS-related biomarkers. Notably, all the OBSs were associated—to a varying degree—with a reduced risk of cardiovascular diseases, chronic kidney disease, colorectal adenomas, and di erent cancer types (colorectal and breast cancer), as well as with all-cause and cancer-related mortality. For other outcomes, e.g., prostate cancer, contradictory results were reported. In summary, there is a great heterogeneity in the definition of OBSs. Most studies are concordant in supporting that excessive OS reflected by a lower OBS has deleterious e ects on health. Unified criteria for defining the proper OBSs, valuable to gauge OS-related aspects of the diet and lifestyle that may lead to adverse health outcomes, are needed.This research was co-funded by the Health Research Fund (FIS), Acción Estratégica en Salud (AES), of the Spanish Ministry of Economy and Competitiveness, grant number PI12/00002, and the European Regional Development Fund (ERDF)

    Oxidative Balance Scores (OBSs) Integrating Nutrient, Food and Lifestyle Dimensions: Development of the NutrientL-OBS and FoodL-OBS

    Get PDF
    This research was co-funded by the Health Research Found (FIS), Accion Estrategica en Salud (AES), of the Spanish Ministry of Economy and Competitiveness, grant number PI12/00002, and the European Regional Development Fund (ERDF).Oxidative Balance Scores (OBS) are tools that allow us to assess the individual's antioxidant state by ranking both antioxidant and pro-oxidant components of dietary and lifestyle factors. Our aim was to develop novel OBSs accounting for either the global supply of nutrient antioxidants in the diet, or the intake of antioxidant-rich foods, in combination with lifestyle factors. Pro-oxidant factors were also considered. Within two centers of the Spanish European Prospective Investigation into Cancer and Nutrition (EPIC) study, EPIC-Granada and EPIC-Gipuzkoa (N = 14,756 participants), we developed the Nurient, Food and Lifestyle OBS (NutrientL-OBS and FoodL-OBS), and their simplified versions (solely with dietary or lifestyle factors, the Nutrient-OBS, Food-OBS and L-OBS). Their antioxidant potential was evaluated considering their relationship with: (i) 20 scores of adherence to the Mediterranean Diet (MD); and, (ii) 25 biomarkers of antioxidant nutrients (ascorbic acid, beta-carotene, etc.), inflammation (CRP, TNF-alpha, etc.) and oxidative stress (uric acid), among 210 participants. Spearman correlation and multivariate linear regression analyses were applied to analyze these associations. Some statistically significant relationships were encountered between the NutrientL-OBS and the FoodL-OBS with the MD scores, and with ascorbic acid (per one-unit increase in OBS: beta = 0.012 and 0.015; p = 0.022 and 0.008, respectively) and CRP (per one-unit increase in both OBS: beta = -0.02; p = 0.02); the latter appeared to be restricted to the OBS ' s lifestyle components. In conclusion, the NutrientL- and FoodL-OBSs and their sub-versions are related to antioxidant-rich dietary patterns and to biomarkers of antioxidant nutrient intake and inflammation, supporting that these tools are valid to assess the individual ' s oxidative/antioxidant status.Health Research Found (FIS), Accion Estrategica en Salud (AES), of the Spanish Ministry of Economy and Competitiveness PI12/00002European Commissio

    A review of a priori defined oxidative balance scores relative to their components and impact on health outcomes

    Get PDF
    Oxidative Balance Scores (OBSs) are tools that have emerged to evaluate the global balance of individuals’ oxidation—reduction status. The aim was to compare OBSs available in the literature regarding their characteristics and associations with chronic diseases in epidemiological studies. Studies that developed OBSs were searched in PubMed until August 2018. A total of 21 OBSs were identified. These OBSs presented different scoring schemes and different types of anti- and pro-oxidant components, including dietary factors (dietary intake and/or nutrient biomarkers), lifestyle factors, and medications. Most OBSs were based on over 10 components, and some included only dietary factors. Few considered weighted components in the score. Only three OBSs were validated as potential surrogates of oxidative balance through inflammation and OS-related biomarkers. Notably, all the OBSs were associated—to a varying degree—with a reduced risk of cardiovascular diseases, chronic kidney disease, colorectal adenomas, and different cancer types (colorectal and breast cancer), as well as with all-cause and cancer-related mortality. For other outcomes, e.g., prostate cancer, contradictory results were reported. In summary, there is a great heterogeneity in the definition of OBSs. Most studies are concordant in supporting that excessive OS reflected by a lower OBS has deleterious effects on health. Unified criteria for defining the proper OBSs, valuable to gauge OS-related aspects of the diet and lifestyle that may lead to adverse health outcomes, are needed

    Evidence Update on the Relationship between Diet and the Most Common Cancers from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: A Systematic Review

    Get PDF
    FundingE.U.-G. is supported by the Programa Operativo Fondo Social Europeo (FSE) de Andalucia (20142020) and Junta de Andalucia (reference DOC_01618).The European Prospective Investigation into Cancer and Nutrition (EPIC) is a multicentre prospective study conducted in 23 centres in 10 European countries. Here we review the findings from EPIC on the relationship between diet-related exposures and incidence or mortality from the four most frequent cancers in the European population: colorectal, breast, lung, and prostate cancer. We conducted a systematic review following PRISMA guidelines and identified 110 high-quality studies based on the EPIC cohort. Fruit and vegetable consumption had a protective effect against colorectal, breast, and lung cancer, whereas only fruit had a protective effect against prostate cancer. A higher consumption of fish and lower consumption of red and processed meat were related with a lower risk of colorectal cancer; and higher consumption of fatty fish with lower risk of breast cancer. Calcium and yogurt intake were found to protect against colorectal and prostate cancer. Alcohol consumption increased the risk for colorectal and breast cancer. Finally, adherence to the Mediterranean diet emerged as a protective factor for colorectal and breast cancer. The EPIC study results are in agreement with the latest evidence from leading authorities on cancer prevention and help to inform public prevention policies and strategies.Programa Operativo Fondo Social Europeo (FSE) de Andalucia (20142020)Junta de Andalucia DOC_0161

    Association Between Egg Consumption and Dementia Risk in the EPIC-Spain Dementia Cohort

    Get PDF
    Current evidence suggests that egg composition might have potential neuroprotective effects. Our aim was to determine the association between egg consumption and the risk of dementia in a Mediterranean population. MethodsThis study was carried out in 3 centers from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain Dementia Cohort, i.e., 25,015 participants aged 30-70 years, recruited in 1992-1996, and followed up for a mean of 21.5 years. ResultsA total of 774 incident dementia cases were diagnosed and validated, of which 518 were Alzheimer's disease (AD). Data on egg consumption were estimated using a validated dietary history questionnaire at recruitment. Cox proportional hazards models, adjusted for confounders, were used in the analyses. No association was observed between egg consumption and either total dementia [hazard ratio between extreme quartiles (HRQ4vs.Q1: 1.05; 95% CI 0.85-1.31; p-trend = 0.93)] or AD (HRQ4vs.Q1 0.93; 95% CI 0.72-1.21; p-trend = 0.50) risks. After dividing the population by adherence to the relative Mediterranean diet (rMED) score, a borderline inverse association was found between egg intake and both total dementia (HRQ4vs.Q1: 0.52; 95% CI 0.30-0.90; p-trend = 0.10) and AD (HRQ4vs.Q1: 0.52; 95% CI 0.27-1.01; p-trend = 0.13) risks within participants with low adherence to rMED score. However, no association was observed in participants with medium and high adherence to rMED score. ConclusionThis prospective study suggests that egg consumption is associated with a reduced risk of dementia, and specifically of AD, in the adult population with low adherence to rMED score; whereas it has no impact in subjects with moderate and high MD adherence

    Sociodemographic profile and description of the presenting symptom in women with breast cancer in a population-based study: Implications and role for nurses

    Get PDF
    Describir la frecuencia y tipología del síntoma de presentación de las mujeres diagnosticadas de cáncer de mama en España así como su perfil sociodemográfico. Estudio descriptivo anidado en un estudio epidemiológico poblacional (MCC-SPAIN) en 10 provincias españolas. Entre 2008 y 2012 se reclutaron 836 casos histológicamente confirmados de cáncer de mama que refirieron algún síntoma previo al diagnóstico en entrevista directa informatizada. Para la comparación de 2 variables discretas se empleó el test de la Chi cuadrado de Pearson. El síntoma de presentación más frecuente entre las mujeres que refirieron como mínimo un síntoma fue notarse un bulto en la mama (73%), seguido de lejos por notar cambios en la mama (11%). Se observó heterogeneidad en la frecuencia del síntoma de presentación a nivel geográfico, y con estado menopáusico. No se observó asociación entre tipo de síntoma de presentación y el resto de variables sociodemográficas exploradas, salvo para nivel de estudios donde las mujeres con un nivel de estudios mayor tendieron a reportar proporcionalmente otros síntomas diferentes al nódulo en la mama con mayor frecuencia que las mujeres con menos estudios. Las mujeres posmenopáusicas refirieron notar cambios en la mama (13%) con mayor frecuencia que las mujeres premenopáusicas (8%), aunque sin llegar a la significación estadística (p = 0,056). El síntoma de presentación más frecuente es la aparición de un «bulto en la mama», seguido por «cambios en la mama». Podría existir heterogeneidad sociodemográfica del tipo de síntoma de presentación a tener en cuenta por las enfermeras en sus intervenciones socio-sanitariasTo describe the frequency and typology of the presenting symptom of women diagnosed of breast cancer in Spain and their socio-demographic profile. Descriptive study nested in a population epidemiological study (MCC-SPAIN) in 10 Spanish provinces. Between 2008 and 2012, 836 histologically confirmed incident cases of breast cancer were recruited who reported some symptom prior to diagnosis in a direct computerized interview. For the comparison of 2 discrete variables, the Pearson Chi square test was used. The most frequent presenting symptom among women who reported at least one symptom was noticing a «lump in the breast» (73%), followed far behind by noticing «changes in the breast» (11%). The frequency of the presenting symptom showed some geographic heterogeneity as well as with menopausal status. No association was observed between the type of presenting symptom and the rest of the sociodemographic variables explored, except for the educational level in which women with a higher educational level tended to proportionally report other symptoms different from the «lump in the breast» more frequently than less educated. Postmenopausal women reported noticing changes in the breast (13%) more frequently than premenopausal women (8%), although without reaching statistical significance (P = .056). The most frequent presenting symptom is «breast lump», followed by «breast changes». There could be sociodemographic heterogeneity in the type of presenting symptom to be taken into account by nurses in their socio-sanitary interventionsEl estudio fue financiado por las subvenciones PI12/00150 y PI17CIII/00034 del Instituto de Salud Carlos III-FEDER-Una manera de construir Europa, así como por la «Acción transversal del cáncer», aprobada por el Ministerio de Ciencia el 11 de octubre de 2007, y por otras ayudas competitivas del Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PI09/00773, PI09/01286, PI09/01903, PI09/02078, PI09/01662, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI14/01219, PI14/0613, PI15/00069, PI17/02286), de la Fundación Marqués de Valdecilla (API10/09), de la Consejería de Salud de la Junta de Andalucía (2009-S0143), de la Fundación Caja de Ahorros de Asturias y por la Universidad de Oviedo, por la Agencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR) de Beca de la Generalitat de Catalunya 2017SGR723, de la Asociación Española Contra el Cáncer (AECC) Fundación Científica beca GCTRA18022MORE. Universidad de Huelva. Junta de Andalucía (Fondos FEDER) UHU-20207

    A Set of Reliable Samples for the Study of Biomarkers for the Early Diagnosis of Parkinson's Disease

    Get PDF
    BackgroundParkinson's disease (PD) is a progressive neurodegenerative disorder, diagnosed according to the clinical criteria that occur in already advanced stages of PD. The definition of biomarkers for the early diagnosis of PD represents a challenge that might improve treatment and avoid complications in this disease. Therefore, we propose a set of reliable samples for the identification of altered metabolites to find potential prognostic biomarkers for early PD. MethodsThis case-control study included plasma samples of 12 patients with PD and 21 control subjects, from the Spanish European Prospective Investigation into Cancer and Nutrition (EPIC)-Navarra cohort, part of the EPIC-Spain study. All the case samples were provided by healthy volunteers who were followed-up for 15.9 (+/- 4.1) years and developed PD disease later on, after the sample collection. Liquid chromatography coupled to tandem mass spectrometry was used for the analysis of samples. ResultsOut of 40 that were selected and studied due to their involvement in established cases of PD, seven significantly different metabolites between PD cases and healthy control subjects were obtained in this study (benzoic acid, palmitic acid, oleic acid, stearic acid, myo-inositol, sorbitol, and quinolinic acid). These metabolites are related to mitochondrial dysfunction, the oxidative stress, and the mechanisms of energy production. ConclusionWe propose the samples from the EPIC study as reliable and invaluable samples for the search of early biomarkers of PD. Likewise, this study might also be a starting point in the establishment of a well-founded panel of metabolites that can be used for the early detection of this disease.he EPIC study received financial support from the International Agency for Research on Cancer (AEP/93/06), the European Commission (SO-97-200302-05F02 and SP23-CT-2005-006438), the Health Research Fund (FIS) of the Spanish Ministry of Health, the Red Temática de Investigación Cooperativa de Centros de Cáncer (RTICCC C03/10 and RD06/0020), the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), the participating Regional Governments of Andalusia, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology (ICO). This study was furthermore supported by the Ministry of Health of the Basque Government, Exp 20161109
    corecore